FDA grants Novavax COVID-19 vaccine full approval but restricts use to adults over 65 and higher-risk individuals, reflecting Trump administration’s vaccine skepticism.
Read the full story at The Associated Press
From the May 17, 2025 GovBrief, every story that day in one place.